Health Related Quality of Life (HRQoL) in Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review (SLR) and Meta-Analysis

被引：0
|
作者：
Banerjee, Rahul [1 ]
Hasegawa, Ken [2 ]
Itani, Taha [2 ]
Giordana, Monique [2 ]
Granados, Enrique [2 ]
Rosado, Margrit B. [3 ]
Chan, Rebecca J. [3 ]
Kostic, Ana [3 ]
Kanters, Steve [4 ]
Zoratti, Michael J. [4 ]
Leleu, Xavier [5 ]
机构：
[1] Fred Hutchinson Canc Ctr, Seattle, WA USA
[2] Kite, Gilead Co, Santa Monica, CA USA
[3] Arcellx Inc, Redwood City, CA USA
[4] RainCity Analyt, Vancouver, BC, Canada
[5] CHU Poitiers, Poitiers, France
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-203741
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4721 / 4722
页数：2
相关论文
共 50 条
  • [21] A SYSTEMATIC LITERATURE REVIEW OF ECONOMIC EVALUATIONS RELATED TO PATIENTS WITH RELAPSED OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Rizzo, M.
    Xu, Y.
    Panjabi, S.
    Iheanacho, I.
    VALUE IN HEALTH, 2014, 17 (03) : A228 - A228
  • [22] Symptom burden and health-related quality of life (HRQoL) in platinum-resistant or -refractory ovarian cancer (PROC): A systematic literature review (SLR)
    Indukuri, N.
    Chen, Z.
    Payer, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1115 - S1116
  • [23] Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis
    Luo, Ying
    Li, Chen
    Niu, Yuanchen
    Wu, Shuanzhi
    Tian, Jingyuan
    Hu, Zhiqin
    He, Jin
    Zhang, Zhixin
    Liu, Haiyan
    Li, Yongmei
    Wang, Tenghua
    Fang, Yi
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (4-5) : 127 - 134
  • [24] Efficacy of ixazomib for the treatment of relapsed/refractory multiple myeloma A protocol of systematic review and meta-analysis
    Li, Zhi
    Guo, Shu-Li
    Wang, Wan-Li
    MEDICINE, 2020, 99 (20)
  • [25] Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies
    Minakata, Daisuke
    Fujiwara, Shin-ichiro
    Yokoyama, Daizo
    Noguchi, Atsuto
    Aoe, Shuka
    Oyama, Takashi
    Koyama, Shunsuke
    Murahashi, Rui
    Nakashima, Hirotomo
    Hyodo, Kazuki
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Toda, Yumiko
    Ito, Shoko
    Nagayama, Takashi
    Mashima, Kiyomi
    Umino, Kento
    Morita, Kaoru
    Ashizawa, Masahiro
    Yamamoto, Chihiro
    Hatano, Kaoru
    Sato, Kazuya
    Ohmine, Ken
    Kanda, Yoshinobu
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (06) : 694 - 703
  • [26] Efficacy of Venetoclax Based Regimens in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis
    Hashim, Laila
    Faisal, Muhammad Salman
    Ahmed, Zahoor
    Selene, Insija Ilyas
    Shahzad, Moazzam
    Abdullah, Syed Maaz
    Samhouri, Yazan
    Yasir, Muhammad
    Wahab, Ahsan
    Ehsan, Hamid
    Neupane, Karun
    Anwer, Faiz
    Fazal, Salman
    BLOOD, 2020, 136
  • [27] Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) receiving real-life standard of care (SOC) treatments: results from the LocoMMotion study
    Delforge, Michel
    Moreau, Philippe
    Einsele, Hermann
    De Stefano, Valerio
    Lindsey-Hill, Joanne
    Vincent, Laure
    Mangiacavalli, Silvia
    Perrot, Aurore
    Ocio, Enrique
    ten Seldam, Silene
    Groen-Damen, Ester in'T
    Semerjian, Maria
    Strulev, Vadim
    Schecter, Jordan
    Roccia, Tito
    Gries, Katharine
    Nesheiwat, Tonia
    Wapenaar, Robert
    Mateos, Maria-Victoria
    Weisel, Katja
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S166 - S167
  • [28] Elotuzumab in combination with pomalidomide and dexamethasone (EloPd) in relapsed refractory multiple myeloma (RRMM): a network meta-analysis
    Farrell, James
    Bertin, Nicolas
    Fischer, Claire
    Gauthier, Aline
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S169 - S170
  • [29] HEALTH RESOURCE UTILIZATION (HRU) AND COSTS OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN THE UNITED STATES (US): A SYSTEMATIC LITERATURE REVIEW
    Hansen, D. K.
    Hasegawa, K.
    Itani, T.
    Giordana, M.
    Granados, E.
    Rosado, M. B.
    Chan, R. J.
    Kostic, A.
    Zannat, N. E.
    Lakzadeh, P.
    Mateos, M., V
    VALUE IN HEALTH, 2024, 27 (12)
  • [30] Effect modification in network meta-analyses for relapsed/refractory multiple myeloma: systematic review and meta-analysis
    Rose, Christopher James
    Ohm, Ingrid Kristine
    Giske, Liv
    Naess, Gunn Eva
    Fretheim, Atle
    BMJ OPEN, 2023, 13 (08):
12345